GlassScriptPhysician profile
Jeffrey Kyle Farrington
NPI 1639757123
$902.88
in general payments reported to CMS, 2019-2025
11 companies · $665 in 2025
The $665 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.01 · 2022: $122 · 2023: $101 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711 · Education: $54.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.80 |
| Education | $54.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $170.08 | 2025 | Prospera |
| Glaxosmithkline, LLC. | $122.11 | 2022 | |
| Avanos Medical | $118.60 | 2025 | Coolief Cooled Radiofrequency |
| Globus Medical, INC. | $113.28 | 2025 | Senza |
| Spr Therapeutics, INC | $110.00 | 2025 | Sprint Pns System |
| Abbvie INC. | $77.42 | 2023-2025 | |
| Boston Scientific Corporation | $73.29 | 2025 | General - Pain Management |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Mml US, INC. | $37.05 | 2025 | Reactiv8 |
| Ipsen Biopharmaceuticals, INC | $20.04 | 2025 | Dysport |
| Pfizer INC. | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Farrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.